CCCC
Price
$1.38
Change
+$0.02 (+1.47%)
Updated
May 23 closing price
Capitalization
97.99M
74 days until earnings call
FATE
Price
$1.16
Change
-$0.04 (-3.33%)
Updated
May 23 closing price
Capitalization
132.97M
67 days until earnings call
Interact to see
Advertisement

CCCC vs FATE

Header iconCCCC vs FATE Comparison
Open Charts CCCC vs FATEBanner chart's image
C4 Therapeutics
Price$1.38
Change+$0.02 (+1.47%)
Volume$453.37K
Capitalization97.99M
Fate Therapeutics
Price$1.16
Change-$0.04 (-3.33%)
Volume$788.58K
Capitalization132.97M
CCCC vs FATE Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. FATE commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and FATE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 25, 2025
Stock price -- (CCCC: $1.38 vs. FATE: $1.16)
Brand notoriety: CCCC and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 41% vs. FATE: 39%
Market capitalization -- CCCC: $97.99M vs. FATE: $132.97M
CCCC [@Biotechnology] is valued at $97.99M. FATE’s [@Biotechnology] market capitalization is $132.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, both CCCC and FATE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while FATE’s TA Score has 6 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 4 bearish.
  • FATE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, FATE is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а 0.00% price change this week, while FATE (@Biotechnology) price change was +8.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

FATE is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($133M) has a higher market cap than CCCC($98M). FATE YTD gains are higher at: -29.697 vs. CCCC (-61.667). CCCC has higher annual earnings (EBITDA): -102.74M vs. FATE (-176.58M). FATE has more cash in the bank: 279M vs. CCCC (215M). CCCC has less debt than FATE: CCCC (64.4M) vs FATE (85.3M). CCCC has higher revenues than FATE: CCCC (39.8M) vs FATE (13.6M).
CCCCFATECCCC / FATE
Capitalization98M133M74%
EBITDA-102.74M-176.58M58%
Gain YTD-61.667-29.697208%
P/E RatioN/AN/A-
Revenue39.8M13.6M293%
Total Cash215M279M77%
Total Debt64.4M85.3M75%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCFATE
RSI
ODDS (%)
Bullish Trend 5 days ago
77%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TTISX12.100.09
+0.75%
Nuveen Quant Intl Sm Cap Eq Retirement
GQEPX21.400.08
+0.38%
GQG Partners US Select Quality Eq Inv
MBINX30.42-0.04
-0.13%
NYLI Balanced Investor Class
FAPNX12.87-0.04
-0.31%
Fidelity Advisor Healthy Future Z
BSCAX16.28-0.08
-0.49%
Brandes Small Cap Value A